Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

ABSTRACT: The study is testing an intervention of an investigator-developed chemotherapy dose adjustment algorithm. The primary objective of this study is to evaluate the effectiveness of the chemotherapy dose adjustment algorithm for reducing unplanned delays in patients receiving FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin)-type chemotherapy, while maintaining acceptable chemotherapy dose-intensity.

DISEASE(S): Thrombocytopenia,Appendix Cancer,Ampullary Cancer,Colorectal Cancer,Gastric Cancer,Esophageal Cancer,Small Bowel Cancer,Appendiceal Neoplasms

PROVIDER: 2349870 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR